As the Executive Quality Director at Bristol Myers Squibb, Deborah Yglesias plays a pivotal role in shaping the quality assurance landscape within the pharmaceutical industry. With her extensive background in quality systems, Deborah is instrumental in leading quality and compliance operations that ensure the delivery...
As the Executive Quality Director at Bristol Myers Squibb, Deborah Yglesias plays a pivotal role in shaping the quality assurance landscape within the pharmaceutical industry. With her extensive background in quality systems, Deborah is instrumental in leading quality and compliance operations that ensure the delivery of safe and effective products to patients worldwide. Her expertise spans a wide array of areas, including cGMP manufacturing, quality control, and validation projects for both biopharmaceuticals and medical devices. This breadth of knowledge enables her to effectively manage complex quality assurance processes and drive transformational initiatives that foster a robust quality culture across the organization.
Deborah is particularly focused on improving and sustaining the Pharmaceutical Quality System, leveraging her strategic planning skills to implement continuous improvement methodologies. She is dedicated to instilling a mindset of excellence and diligence within her teams, ensuring that every aspect of quality assurance aligns with regulatory standards and best practices. Her leadership style, characterized by patience and persistence, empowers her colleagues to embrace a culture of quality, ultimately enhancing operational efficiency and product reliability.
Key projects under Deborah’s guidance include the optimization of laboratory operations and the execution of comprehensive audits that identify areas for improvement. Her commitment to quality assurance not only safeguards patient health but also reinforces Bristol Myers Squibb's reputation as a leader in the pharmaceutical sector. Through her strategic vision and hands-on approach, Deborah Yglesias continues to make significant contributions to the advancement of quality standards, ensuring that BMS remains at the forefront of innovation and patient care.
